Financhill
Back

Immunovant Stock Predictions

Immunovant Stock Forecast

  • Over the next 52 weeks, Immunovant has on average historically risen by 43.6% based on the past 5 years of stock performance.
  • Immunovant has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Immunovant Stock Undervalued?
    The current Immunovant [IMVT] share price is $19.69. The Score for IMVT is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • IMVT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Immunovant Stock Go Up Next Year?

  • Over the next 52 weeks, Immunovant has on average historically risen by 43.6% based on the past 5 years of stock performance.

Immunovant Stock Rating

Sell
14
Immunovant (IMVT) is a Sell

Is Immunovant overpriced?

  • Immunovant has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Immunovant Stock Price History

Is IMVT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IMVT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunovant.com

52-Week Data

52-Week High:
35.97
52-Week Low:
17.01

Prediction Charts

Market Cap:
3.3B
Price in USD:
19.69
Volume:
3.3M
Beta:
0.70

Technical Analysis

SMA50:
21.20
SMA100:
24.58
SMA200:
26.68
52-Wk Change:
-37.63%

Stock Predictions

  • Is Immunovant stock public?
    Yes, Immunovant is a publicly traded company.
  • What is the Immunovant stock quote today?
    The Immunovant stock price is 19.69 USD today.
  • How to buy Immunovant stock online?
    You can buy Immunovant shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-28 20.26 20.61 20.80 20.00
Mar-3 20.25 18.42 20.69 18.13
Mar-4 18.26 18.47 18.67 17.65
Mar-5 18.63 19.42 19.55 18.63
Mar-6 19.17 19.51 19.88 19.16
Mar-7 19.45 20.02 20.03 18.85
Mar-11 20.25 19.61 20.35 19.39
Mar-12 19.69 19.12 19.83 18.94
Mar-13 19.39 18.79 19.60 18.57
Mar-14 18.94 19.52 19.52 18.70
Mar-17 19.60 20.02 20.22 19.37
Mar-18 19.87 18.79 19.89 18.77
Mar-19 17.41 18.88 20.44 17.01
Mar-20 18.64 19.69 20.33 18.51

Immunovant Earnings

Immunovant Earnings Report: Per Share Immunovant Earnings Q1 Q2 Q3 and Q4 last year and next year.

Immunovant Forecast Revenue Growth

Immunovant Stock Analysis: Historical quarterly revenues per share for Immunovant and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.01 per share, a decrease this year of $1.18 per share, and a decrease next year of $0.03 per share.

* Immunovant stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.